Catalyst Pharmaceuticals ... (CPRX)
NASDAQ: CPRX
· Real-Time Price · USD
20.53
-0.73 (-3.43%)
At close: Oct 16, 2025, 3:59 PM
20.53
0.00%
After-hours: Oct 16, 2025, 07:50 PM EDT
-3.43% (1D)
| Bid | 20.4 |
| Market Cap | 2.51B |
| Revenue (ttm) | 558.5M |
| Net Income (ttm) | 208.66M |
| EPS (ttm) | 1.65 |
| PE Ratio (ttm) | 12.44 |
| Forward PE | 12.02 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 21.5 |
| Volume | 1,455,926 |
| Avg. Volume (20D) | 1,512,301 |
| Open | 21.18 |
| Previous Close | 21.26 |
| Day's Range | 20.41 - 21.27 |
| 52-Week Range | 19.05 - 26.58 |
| Beta | 0.79 |
| Ex-Dividend Date | n/a |
About CPRX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CPRX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CPRX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsCatalyst Pharmaceuticals Inc. is scheduled to release its earnings on
Nov 5, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
-9.87%
Catalyst Pharmaceuticals shares are trading lower....
Unlock content with
Pro Subscription
5 months ago
-2.98%
Catalyst Pharmaceuticals shares are trading lower after the company issued FY25 sales guidance below estimates.
2 months ago · seekingalpha.com
Catalyst Pharmaceuticals, Inc. (CPRX) Q2 2025 Earnings Call TranscriptCatalyst Pharmaceuticals, Inc. (NASDAQ:CPRX ) Q2 2025 Earnings Conference Call August 7, 2025 8:30 AM ET Company Participants Jeffrey Del Carmen - Executive VP & Chief Commercial Officer Michael W. Ka...
